User profiles for M. Sharland
sharland mProfessor of Paediatric Infectious Diseases, St George's University London Verified email at sgul.ac.uk Cited by 30535 |
Neonatal sepsis: an international perspective
S Vergnano, M Sharland, P Kazembe… - Archives of Disease in …, 2005 - fn.bmj.com
Neonatal infections currently cause about 1.6 million deaths annually in developing countries.
Sepsis and meningitis are responsible for most of these deaths. Resistance to commonly …
Sepsis and meningitis are responsible for most of these deaths. Resistance to commonly …
Surveillance for control of antimicrobial resistance
…, M van Mourik, A Voss, M Sharland… - The Lancet Infectious …, 2018 - thelancet.com
Antimicrobial resistance poses a growing threat to public health and the provision of health
care. Its surveillance should provide up-to-date and relevant information to monitor the …
care. Its surveillance should provide up-to-date and relevant information to monitor the …
Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management
…, J Saavedra-Lozano, T Shah, M Sharland… - The Pediatric …, 2017 - journals.lww.com
Despite the significant long-term impact of cCMV infection, there is limited evidence on
which to base many treatment decisions in clinical practice. In an era of enhanced perinatal …
which to base many treatment decisions in clinical practice. In an era of enhanced perinatal …
[HTML][HTML] Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
…, JAG Scott, S Seekaew, M Sharland, M Shivamallappa… - The lancet, 2022 - thelancet.com
Background Antimicrobial resistance (AMR) poses a major threat to human health around
the world. Previous publications have estimated the effect of AMR on incidence, deaths, …
the world. Previous publications have estimated the effect of AMR on incidence, deaths, …
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
…, M Sanguinetti, S Sengupta, M Sharland… - The Lancet infectious …, 2018 - thelancet.com
Background The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity
and mortality worldwide. Due to its large public health and societal implications, multidrug-…
and mortality worldwide. Due to its large public health and societal implications, multidrug-…
[HTML][HTML] A living WHO guideline on drugs for covid-19
…, S Sabzwari, R Sarin, M Shankar-Hari, M Sharland… - bmj, 2020 - myderfinanzen.com
… Most patients are at low risk Moderate M Patients at moderate risk of hospital admission (3%)
Includes people: over 65 years old with obesity with diabetes with active cancer with …
Includes people: over 65 years old with obesity with diabetes with active cancer with …
[HTML][HTML] Valganciclovir for symptomatic congenital cytomegalovirus disease
…, J Homans, AL Shane, M Sharland… - … England Journal of …, 2015 - Mass Medical Soc
Background The treatment of symptomatic congenital cytomegalovirus (CMV) disease with
intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 …
intravenous ganciclovir for 6 weeks has been shown to improve audiologic outcomes at 6 …
A clinical study of Noonan syndrome.
M Sharland, M Burch, WM McKenna… - Archives of disease in …, 1992 - adc.bmj.com
Clinical details are presented on 151 individuals with Noonan syndrome (83 males and 68
females, mean age 12.6 years). Polyhydramnios complicated 33% of affected pregnancies. …
females, mean age 12.6 years). Polyhydramnios complicated 33% of affected pregnancies. …
A living WHO guideline on drugs for covid-19
…, S Sabzwari, R Sarin, M Shankar-Hari, M Sharland… - bmj, 2020 - bmj.com
Updates This is the thirteenth version (twelfth update) of the living guideline, replacing earlier
versions (available as data supplements). New recommendations will be published as …
versions (available as data supplements). New recommendations will be published as …
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data
…, KK Tseng, M Sharland… - The Lancet Infectious …, 2021 - thelancet.com
Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework
aims to balance appropriate access to antibiotics and stewardship. We aimed to identify …
aims to balance appropriate access to antibiotics and stewardship. We aimed to identify …